80 related articles for article (PubMed ID: 1723903)
21. Characterization of the CA 125 antigen associated with human epithelial ovarian carcinomas.
Davis HM; Zurawski VR; Bast RC; Klug TL
Cancer Res; 1986 Dec; 46(12 Pt 1):6143-8. PubMed ID: 2430690
[TBL] [Abstract][Full Text] [Related]
22. Biochemical analysis of human ovarian cancer-associated antigens defined by murine monoclonal antibodies.
Miotti S; Aguanno S; Canevari S; Diotti A; Orlandi R; Sonnino S; Colnaghi MI
Cancer Res; 1985 Feb; 45(2):826-32. PubMed ID: 2981614
[TBL] [Abstract][Full Text] [Related]
23. Clinical significance of cancer antigen 125 (CA 125) in ovarian cancer.
Crombach G; Zippel HH; Würz H
Cancer Detect Prev; 1985; 8(1-2):135-9. PubMed ID: 3864535
[TBL] [Abstract][Full Text] [Related]
24. [Immunochemical identification and physico-chemical characteristics of specific proteins of seminal plasma].
Shevchenko OP; Petrunin DD; Tatarinov IuS
Biull Eksp Biol Med; 1982 Oct; 94(10):80-1. PubMed ID: 6184090
[TBL] [Abstract][Full Text] [Related]
25. [Immunochemical determination of placenta-specific and interorganic antigens in placental extract and blood serum in pregnant rats].
Kan MF; Krivonosov SK; Tatarinova IuS
Biull Eksp Biol Med; 1985 Apr; 99(4):466-7. PubMed ID: 2580577
[TBL] [Abstract][Full Text] [Related]
26. Characterization of glycoconjugates released in vitro by human ovarian carcinoma cells isolated from effusions.
Allen HJ; Gamarra M; Piver MS; Johnson EA
Cancer Biochem Biophys; 1991 Jun; 12(1):9-22. PubMed ID: 1769007
[TBL] [Abstract][Full Text] [Related]
27. Trophoblast and ovarian cancer antigen LK26. Sensitivity and specificity in immunopathology and molecular identification as a folate-binding protein.
Garin-Chesa P; Campbell I; Saigo PE; Lewis JL; Old LJ; Rettig WJ
Am J Pathol; 1993 Feb; 142(2):557-67. PubMed ID: 8434649
[TBL] [Abstract][Full Text] [Related]
28. [Placental-renal prealbumin: immunochemical identification, physico-chemical characteristics and affinity chromatography on immobilized steroids].
Kalinin IuA; Efremov AD; Terent'ev AA; Tatarinov IuS
Vopr Med Khim; 1992; 38(3):38-9. PubMed ID: 1413648
[TBL] [Abstract][Full Text] [Related]
29. Tumor-associated antigen(s) from granulosa cell carcinomas of the ovary.
Bhattacharya M; Barlow JJ; Chu TM; Piver MS
Cancer Res; 1974 Apr; 34(4):818-22. PubMed ID: 4205513
[No Abstract] [Full Text] [Related]
30. Identification of two different surface epitopes of human ovarian epithelial carcinomas by monoclonal antibodies.
Tsuji Y; Suzuki T; Nishiura H; Takemura T; Isojima S
Cancer Res; 1985 May; 45(5):2358-62. PubMed ID: 2580620
[TBL] [Abstract][Full Text] [Related]
31. Evidence for in vivo breakdown of beta-10-globulin in hypocomplementemic glomerulonephritis.
West CD; Winter S; Forristal J; McConville JM; Davis NC
J Clin Invest; 1967 Apr; 46(4):539-48. PubMed ID: 4164258
[TBL] [Abstract][Full Text] [Related]
32. Cloning of a tumor-associated antigen: MOv18 and MOv19 antibodies recognize a folate-binding protein.
Coney LR; Tomassetti A; Carayannopoulos L; Frasca V; Kamen BA; Colnaghi MI; Zurawski VR
Cancer Res; 1991 Nov; 51(22):6125-32. PubMed ID: 1840502
[TBL] [Abstract][Full Text] [Related]
33. [Immunochemical study of carcinocerebral alpha2-globulin and carcinoembryonic antigen in ovarian tumors].
Borisenko SA; Kalashnikov VV; Kulagin PP; Chishieva MA
Akush Ginekol (Mosk); 1976 Jul; (7):63-5. PubMed ID: 65926
[No Abstract] [Full Text] [Related]
34. [Immunochemical study of alpha-1 organospecific antigen in different sections of the brain and CNS tumors].
Obukhov SK; Kasumova SIu; Kalashnikov VV
Vopr Onkol; 1981; 27(2):61-4. PubMed ID: 6163253
[TBL] [Abstract][Full Text] [Related]
35. Further characterization of CSAp, an antigen associated with gastrointestinal and ovarian tumors.
Pant KD; Dahlman HL; Goldenberg DM
Cancer; 1978 Sep; 42(3 Suppl):1626-34. PubMed ID: 81713
[TBL] [Abstract][Full Text] [Related]
36. Monoclonal antibodies against ovarian carcinoma-associated antigens, raised by immunization with cyst fluids.
Boerman O; Makkink K; Massuger L; Thomas C; Kenemans P; Hanselaar T; Poels L
Anticancer Res; 1989; 9(3):551-8. PubMed ID: 2764501
[TBL] [Abstract][Full Text] [Related]
37. Identification and characterization of serum protein in patients with ovarian cancer.
Prokopenko PG; Borisenko SA; Sokolov AV; Terentyev AA
Bull Exp Biol Med; 2002 Feb; 133(2):156-9. PubMed ID: 12428284
[TBL] [Abstract][Full Text] [Related]
38. [Immuno-serologic examinations in pregnancy and genital neoplasms in women].
Kadach D
Zentralbl Gynakol; 1970 Nov; 92(48):1577-80. PubMed ID: 4099855
[No Abstract] [Full Text] [Related]
39. Monoclonal antibody against human ovarian tumor-associated antigens.
Poels LG; Peters D; van Megen Y; Vooijs GP; Verheyen RN; Willemen A; van Niekerk CC; Jap PH; Mungyer G; Kenemans P
J Natl Cancer Inst; 1986 May; 76(5):781-91. PubMed ID: 3517452
[TBL] [Abstract][Full Text] [Related]
40. Reactivity of monoclonal antibody DF3 with a high molecular weight antigen expressed in human ovarian carcinomas.
Friedman EL; Hayes DF; Kufe DW
Cancer Res; 1986 Oct; 46(10):5189-94. PubMed ID: 3530435
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
